Back
Standard BioTools 10K Form
Sell
41
LAB
Standard BioTools
Last Price:
1.65
Seasonality Move:
14.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LAB News And Ratings
See the #1 stock for the next 7 days that we like better than LAB
LAB Financial Statistics
Sales & Book Value
| Annual Sales: | $106.34M |
|---|---|
| Cash Flow: | $-30.12M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.31 |
| Price / Book: | 1.23 |
Profitability
| EPS (TTM): | -0.71000 |
|---|---|
| Net Income (TTM): | $-124.59M |
| Gross Margin: | $50.45M |
| Return on Equity: | -48.03% |
| Return on Assets: | -22.01% |
Standard BioTools Earnings Forecast
Key Standard BioTools Financial Ratios
- The Gross Profit Margin over the past 18 years for LAB is 47.44%.
- The Selling, General & Administrative Expenses for LAB have been equal to 82.32% of Gross Profit Margin.
- The Research & Development expenses have been 24.40% of Revenue.
- The Interest Expense is -6.12% of Operating Income.
- The Net Earning history of LAB is -70.21% of Total Revenues.
- Per Share Earnings over the last 18 years have been positive in 10 years.
Standard BioTools Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | LAB |
| Website: | standardbio.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 3.76 |
| Quick Ratio: | 3.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LAB Technical Analysis vs Fundamental Analysis
Sell
41
Standard BioTools (LAB)
is a Sell
Is Standard BioTools a Buy or a Sell?
-
Standard BioTools stock is rated a Sell
The current Standard BioTools [LAB] share price is $1.62. The Score for LAB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.